[Key specialties edition] Outpatient vs. inpatient orthopedic procedures: Where are the cost-savings? | Valeant Pharmaceuticals’ Salix to pay $54M for alleged illegal kickbacks: 6 things to know | Pain management device market to hit $4.64B by 2021: 5 things to know | Zimmer Biomet to acquire LDR in $1B transaction – 9 things to know


From: Becker’s ASC Review <editorial@beckershealthcare.com>
Subject: [Key specialties edition] Outpatient vs. inpatient orthopedic procedures: Where are the cost-savings? | Valeant Pharmaceuticals’ Salix to pay $54M for alleged illegal kickbacks: 6 things to know | Pain management device market to hit $4.64B by 2021: 5 things to know | Zimmer Biomet to acquire LDR in $1B transaction – 9 things to know
Preheader:
Reply: editorial@beckershealthcare.com

TextView our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube
        

                                                                 

June 21, 2016

Today’s Top Articles
1. Valeant Pharmaceuticals’ Salix to pay $54M for alleged illegal kickbacks: 6 things to know  Full story    

2. Outpatient vs. inpatient orthopedic procedures: Where are the cost-savings? Full story 

 

3. Zimmer Biomet to acquire LDR in $1B transaction – 9 things to know Full story   

4. Whitepaper: Healthcare consumerism is here – a patient acquisition model that you fully control and own. Click here to learn more and download.

 

5. 8 statistics on payers, new payment models & ophthalmologists Full story

6. From pre-op to post-op: A team-based approach to adding TJR to an ASC Full story

7. Webinar: Learn how to navigate the reimbursement landscape for total joint reconstruction in ASCs. Register today! 

 

8. Outpatient spine driving spinal implants market growth; CAGR of 5.91% to 2020 – 5 observations Full story

 

9. Top 10 states with highest follow-up interval for colonoscopy rates Full story 

 
10. Pain management device market to hit $4.64B by 2021: 5 things to know Full story

11.  Evolutionary vs. revolutionary: The future of surgical devices and spine surgery Full story 

           
    

                                                      
             
  

Channels

_____________________
Contact Us

Editorial Contact:

Laura Dyrda  

Editor-in Chief
Becker’s ASC Review
Becker’s Spine Review
(312) 253-9170
email editorial  

Sales, Marketing & Events:
Jessica Cole
President and CEO

______________________

 


Becker’s ASC | (800) 417-2035 | becker@beckersasc.com | http://www.beckersasc.com
17 N. State St.
Suite 1800
Chicago, IL 60602
Beckers ASC, 17 N. State St., Suite 1800, Chicago, IL 60602
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact